Global Diagnostic Biomarker Market Research and Forecast 2018-2023

 

Contact Information
Anurag Tiwari
116, Shagun Arcade, Vijay Nagar Square
Indore
Madhya Pradesh - 452001
India
+1-646-755-7667, +91-780-304-0404
info@omrglobal.com
 
"The global diagnostic biomarker market is growing due to high number of research institutes focused on diagnostic biomarkers."

According to the OMR analysis, the global Diagnostic biomarker market is growing at a significant rate during 2018-2023. The global Diagnostic biomarker market has witnessed a significant growth due to high number of research institutes focused on diagnostic biomarkers. The global diagnostic biomarker is segmented on the basis of application, diagnostic technique and end-user. The report provides detailed and insightful chapters on market overview, key findings, strategic recommendations, market estimations, market determinants, patent analysis, key company analysis, market insights, company profiling, market segmentation, geographical analysis and analyst insights.

The researches by the different research institutes that are going presently has turned to the diagnosis of the diseases such as cancer, for developing new biomarkers. Presently, the scientists are focusing on the gene expression for detecting the results of therapy process. Recently, National Cancer Institute (NCI) sponsored Trial Assigning Individualized Option for treatment (Rx), or TAILORx. During the test there were several women that were diagnosed recently with lymph node-negative, hormone receptor was positive during test. The number of women observed with the lowest of 21-gene recurrence score were low. The biomarkers test is being utilized to find the risk factor of reoccurrence of the breast cancer. During January 2015 there was an investment made by the Precision Medical Initiative of $70 million to the National Cancer Institute. The investment was made to recognize the different genomic drivers in cancer and to develop new approaches for diagnosis of the cancer. The development of cancer biomarker for the treatment and therapy has been focused on more. Various research work is going on to improve the accuracy of the biomarkers and results response. The National Cancer Institute in March 2016 had earmarked $5.5 million for funding for the establishment of laboratories with an aim to advance research on biomarkers and biomarker assays for various cancers such as of the prostate, lung, breast, and genitourinary organs. The Biomarker Developmental Laboratories (BDLs) will be a part of the early detection research network of the NCI. Within this funding, the NCI's aim is to fund eight to ten BDLs that will be involved in developing and characterizing the new biomarkers and assays or refining the existing ones.

The global diagnostic biomarker market can be segmented on the basis of geography among four major regions-North America, APAC, Europe, and Rest of the world. North America has the significant market share of diagnostic biomarker during forecatesd year. North American market is driven by increasing government support for biomarker discovery and development and growing usage of biomarker in drug discovery & development by the pharmaceutical companies within the region. Asia-Pacific market is expected to have the significant growth amongst all regions during the forecast period of 2018-2023. The high number of research institutes focused on diagnostic biomarker in the APAC region are augmenting the diagnostic biomarker market.

The report covers:
Comprehensive research methodology of global Diagnostic Biomarker market.
This report also includes detailed and extensive market overview with key analyst insights.
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the global Diagnostic Biomarker market.
Insights about market determinants which are stimulating the global Diagnostic Biomarker market.
Detailed and extensive market segments with regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.


About Orion Market Research

Orion Market Research (OMR) is an Indian research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company provides quality syndicated research reports, customized research reports, company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.
For more information, visit: https://www.omrglobal.com/industry-reports/diagnostic-biomarker-market/


Biotechnology, Healthcare

 

If you have any questions regarding information in this press release, please contact the person listed in the Contact / Company information box of this page. Please do not attempt to contact Market Press Release. We will be unable to assist you with any information regarding this release. Market Press Release disclaims any content contained in this press release.